Lieven Annemans

Belgian university teacher

Born 1964-01-01

Lieven Annemans is …
instance of (P31):
humanQ5

External links are
P2671Google Knowledge Graph ID/g/11gj19z2cs
P269IdRef ID137623461
P244Library of Congress authority IDn2016180870
P6634LinkedIn personal profile IDlieven-annemans-3376b46
P1006Nationale Thesaurus voor Auteursnamen ID174237367
P496ORCID iD0000-0001-8305-7210
P3159UGentMemorialis professor ID000003451
P214VIAF ID290255760
P2002X usernameLievenAnnemans

P27country of citizenshipBelgiumQ31
P69educated atVrije Universiteit BrusselQ612665
P108employerGhent UniversityQ1137665
P734family nameAnnemansQ64148965
AnnemansQ64148965
AnnemansQ64148965
P101field of workeconomicsQ8134
healthQ12147
P735given nameLievenQ927099
LievenQ927099
P1412languages spoken, written or signedDutchQ7411
P106occupationuniversity teacherQ1622272
P21sex or gendermaleQ6581097
P8687social media followers13846

Reverse relations

author (P50)
Q280670053D-printing techniques in a medical setting: a systematic literature review
Q28219028A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan
Q90097393A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium
Q28194877A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease
Q38242028A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions
Q90358814A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory
Q53290843Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).
Q33579846Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium
Q34116503Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care
Q35407243Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
Q31049802Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Q36486726Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation
Q36160381Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis
Q36261859Discounting health effects in pharmacoeconomic evaluations: current controversies
Q94684060Do custom 3D-printed revision acetabular implants provide enough value to justify the additional costs? The health-economic comparison of a new porous 3D-printed hip implant for revision arthroplasty of Paprosky type 3B acetabular defects and its cl
Q35890606Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
Q36118072Economic burden of pertussis and the impact of immunization
Q47896295Economic consequences of legal and illegal drugs: The case of social costs in Belgium.
Q36613885Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients
Q35660935Education in pharmacoeconomics: an international multidisciplinary view
Q36212254Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia: design of a comparative study.
Q33868229Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review
Q36182064Effectiveness of Pricing Strategies on French Fries and Fruit Purchases among University Students: Results from an On-Campus Restaurant Experiment
Q38808538Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials
Q34528983Effectiveness of respite care in supporting informal caregivers of persons with dementia: a systematic review
Q38259150Effects of physician-owned specialized facilities in health care: a systematic review
Q34979337EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring
Q35036627Evidence-based health care policy in reimbursement decisions: lessons from a series of six equivocal case-studies
Q93214310Factors Associated with the Caregivers' Desire to Institutionalize Persons with Dementia: A Cross-Sectional Study
Q28563993Fulfillment of administrative and professional obligations of hospitals and mission motivation of physicians
Q38695854Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.
Q28200330Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease
Q34302939Health promotion intervention in mental health care: design and baseline findings of a cluster preference randomized controlled trial
Q33749099Hospital-physician relations: the relative importance of economic, relational and professional attributes to organizational attractiveness
Q42640121How to govern physician-hospital exchanges: contractual and relational issues in Belgian hospitals
Q35622719How to reform western care payment systems according to physicians, policy makers, healthcare executives and researchers: a discrete choice experiment
Q84900787Inventory of European databases related to cardiovascular diseases
Q35923742Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study
Q28217547Medication use and disease management of type 2 diabetes in Belgium
Q37590519Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review
Q30748190Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trial
Q34536093Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making
Q36311047Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
Q34669169Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Q35494124Prevalence and management of antibiotic associated diarrhea in general hospitals
Q34092558Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines
Q38512501Provider accountability as a driving force towards physician-hospital integration: a systematic review.
Q33691253Quality of life after intensive care: A systematic review of the literature
Q30234324Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
Q34481576Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study)
Q88151618Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations
Q33669353Systematic review: Effects, design choices, and context of pay-for-performance in health care
Q35731925The cost of prevention and treatment of pressure ulcers: A systematic review
Q35939263The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
Q97674965The effectiveness and cost-effectiveness of an integrated osteoporosis care programme for postmenopausal women in Flanders: study protocol of a quasi-experimental controlled design
Q34006448The equity dimension in evaluations of the quality and outcomes framework: a systematic review
Q47137304The health-related social costs of alcohol in Belgium
Q47768069The impact of economic and noneconomic exchange on physicians' organizational attitudes: The moderating effects of the Chief Medical Officer
Q35601445The impact of professional and organizational identification on the relationship between hospital-physician exchange and customer-oriented behaviour of physicians
Q33821363The ties that bind: an integrative framework of physician-hospital alignment
Q36166871Using linked administrative and disease-specific databases to study end-of-life care on a population level.
Q35303021Valorising and creating access to innovative medicines in the European union
Q35987708Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases
Q38609637Variations in hospital costs after traffic injuries: The importance of sociodemographic aspects and comorbidities

The articles in Wikimedia projects and languages

      Lieven Annemanswikipedia

Search more.